Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 1 | 1 | 21 | 24 |
| Average estimate | 17.39 | 13.35 | 53.27 | 82.09 |
| Low estimate | 17.39 | 13.35 | 42.80 | 57.48 |
| High estimate | 17.39 | 13.35 | 64.60 | 107.40 |
| Last year EPS | 9.39 | 8.79 | 35.80 | 53.27 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 1 | 1 | 25 | 25 |
| Avg. estimate | 156.20B | 185B | 560.71B | 692.26B |
| Low estimate | 156.20B | 185B | 560.71B | 641.16B |
| High estimate | 156.20B | 185B | 603.23B | 779.75B |
| Last year sales | 117.51B | 131.83B | 488.18B | 560.71B |
| Sales growth | 0.33 | 0.40 | 0.15 | 0.23 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 17.39 | 13.35 | 53.27 | 82.09 |
| 7 days ago | 17.96 | 13.79 | 53.27 | 82.09 |
| 30 days ago | 17.96 | 13.79 | 60.44 | 86.74 |
| 60 days ago | 0 | 0 | 60.44 | 88.21 |
| 90 days ago | 16.16 | 12.41 | 60.93 | 88.26 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 0 | 0 | 2 | 1 |
| Up last 30 days | 0 | 0 | 2 | 2 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 1 | 1 | 13 | 13 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | 0.852% |
| Next qtr. (Feb 2026) | 0.520% |
| Current year (2025) | 0.488% |
| Next 5 years (per annum) | 0.454% |
| Past 5 years (per annum) | 0.383% |
Recommendation
Buy